Show simple item record

dc.contributor.authorRoshan, HR
dc.contributor.authorAzarm, A
dc.contributor.authorMahmoudian, B
dc.contributor.authorIslamian, JP
dc.date.accessioned2018-08-26T05:43:47Z
dc.date.available2018-08-26T05:43:47Z
dc.identifier.urihttp://dspace.tbzmed.ac.ir:8080/xmlui/handle/123456789/40775
dc.description.abstractRadioembolization (RE) with Yttrium-90 ((90)Y) microspheres is an effective treatment for unresectable liver tumors. The activity of the microspheres to be administered should be calculated based on the type of microspheres. Technetium-99m macroaggregated albumin ((99m)Tc-MAA) single photon emission computed tomography/computed tomography (SPECT/CT) is a reliable assessment before RE to ensure the safe delivery of microspheres into the target. (90)Y bremsstrahlung SPECT imaging as a posttherapeutic assessment approach enables the reliable determination of absorbed dose, which is indispensable for the verification of treatment efficacy. This article intends to provide a review of the methods of optimizing (90)Y bremsstrahlung SPECT imaging to improve the treatment efficacy of liver tumor RE using (90)Y microspheres.
dc.language.isoEnglish
dc.relation.ispartofWorld journal of nuclear medicine
dc.titleAdvances in SPECT for Optimizing the Liver Tumors Radioembolization Using Yttrium-90 Microspheres.
dc.typearticle
dc.citation.volume14
dc.citation.issue2
dc.citation.spage75
dc.citation.epage80
dc.citation.indexPubmed
dc.identifier.DOIhttps://doi.org/10.4103/1450-1147.157120


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record